Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 2
1964 1
1965 1
1966 1
1970 3
1972 2
1973 3
1975 1
1976 3
1977 1
1980 1
1982 2
1983 1
1984 2
1985 6
1986 1
1987 2
1988 5
1991 4
1992 2
1993 4
1994 1
1995 1
1996 3
1997 3
1998 3
1999 2
2000 5
2001 1
2002 5
2003 7
2004 8
2005 5
2006 9
2007 5
2008 5
2009 11
2010 11
2011 14
2012 13
2013 11
2014 8
2015 8
2016 14
2017 12
2018 13
2019 15
2020 13
2021 18
2022 23
2023 25
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

299 results

Results by year

Filters applied: . Clear all
Page 1
Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management.
Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer MJ; Autoimmune Encephalitis Alliance Clinicians Network. Abboud H, et al. J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):757-768. doi: 10.1136/jnnp-2020-325300. Epub 2021 Mar 1. J Neurol Neurosurg Psychiatry. 2021. PMID: 33649022 Free PMC article. Review.
Corticosteroids alone or combined with other agents (intravenous IG or plasmapheresis) were selected as a first-line therapy by 84% of responders for patients with a general presentation, 74% for patients presenting with faciobrachial dystonic seizures, 63% for NMDA …
Corticosteroids alone or combined with other agents (intravenous IG or plasmapheresis) were selected as a first-line therapy by 84% o …
Consensus Statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society.
Bhatia KP, Bain P, Bajaj N, Elble RJ, Hallett M, Louis ED, Raethjen J, Stamelou M, Testa CM, Deuschl G; Tremor Task Force of the International Parkinson and Movement Disorder Society. Bhatia KP, et al. Mov Disord. 2018 Jan;33(1):75-87. doi: 10.1002/mds.27121. Epub 2017 Nov 30. Mov Disord. 2018. PMID: 29193359 Free PMC article. Review.
BACKGROUND: Consensus criteria for classifying tremor disorders were published by the International Parkinson and Movement Disorder Society in 1998. ...METHODS: Computerized MEDLINE searches in January 2013 and 2015 were conducted using a combination of text words and MeSH …
BACKGROUND: Consensus criteria for classifying tremor disorders were published by the International Parkinson and Movement Disorder S …
Drug-induced tremor, clinical features, diagnostic approach and management.
Baizabal-Carvallo JF, Morgan JC. Baizabal-Carvallo JF, et al. J Neurol Sci. 2022 Apr 15;435:120192. doi: 10.1016/j.jns.2022.120192. Epub 2022 Feb 19. J Neurol Sci. 2022. PMID: 35220110 Review.
Drug-induced tremor usually resembles essential or parkinsonian tremor, depending on the offending drug; however, features such as unilateral, task-specific, position-dependent tremor or sudden onset, distractibility, entrainment and arrest with contralateral movements suggest et …
Drug-induced tremor usually resembles essential or parkinsonian tremor, depending on the offending drug; however, features such as unilatera …
Diagnosis and Treatment of Essential Tremor.
Wagle Shukla A. Wagle Shukla A. Continuum (Minneap Minn). 2022 Oct 1;28(5):1333-1349. doi: 10.1212/CON.0000000000001181. Continuum (Minneap Minn). 2022. PMID: 36222768 Review.
Differentiating these tremor disorders from essential tremor based on phenomenology and physical examination alone could be challenging; thus, clinicians should seek additional clues from a detailed history. Treatment could begin with noninvasive and nonpharmacologic th …
Differentiating these tremor disorders from essential tremor based on phenomenology and physical examination alone could be challengi …
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.
Niemann N, Jankovic J. Niemann N, et al. Parkinsonism Relat Disord. 2019 Oct;67:74-89. doi: 10.1016/j.parkreldis.2019.06.025. Epub 2019 Jun 30. Parkinsonism Relat Disord. 2019. PMID: 31272925 Review.
Levodopa-responsive juvenile parkinsonism that is consistent with diagnostic criteria for Parkinson's disease is most often caused by mutations in the PARK-Parkin, PARK-PINK1, or PARK-DJ1 genes. However, many other genetic and acquired parkinsonian disorders presenting in …
Levodopa-responsive juvenile parkinsonism that is consistent with diagnostic criteria for Parkinson's disease is most often caused by mutati …
Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins.
Hassell TJW, Charles D. Hassell TJW, et al. Toxins (Basel). 2020 Apr 22;12(4):269. doi: 10.3390/toxins12040269. Toxins (Basel). 2020. PMID: 32331272 Free PMC article. Review.
Blepharospasm and oromandibular dystonia are focal dystonias characterized by involuntary and often patterned, repetitive muscle contractions. There is a long history of medical and surgical therapies, with the current first-line therapy, botulinum neurotoxin (BoNT) …
Blepharospasm and oromandibular dystonia are focal dystonias characterized by involuntary and often patterned, repetitive muscle contraction …
Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity.
Dressler D, Altavista MC, Altenmueller E, Bhidayasiri R, Bohlega S, Chana P, Chung TM, Colosimo C, Fheodoroff K, Garcia-Ruiz PJ, Jeon B, Jin L, Kanovsky P, Milanov I, Micheli F, Orlova O, Pandey S, Pirtosek Z, Relja M, Rosales R, Sagástegui-Rodríguez JA, Shahidi GA, Timerbaeva S, Wan X, Walter U, Saberi FA. Dressler D, et al. J Neural Transm (Vienna). 2021 Mar;128(3):321-335. doi: 10.1007/s00702-021-02312-4. Epub 2021 Feb 26. J Neural Transm (Vienna). 2021. PMID: 33635442 Free PMC article.
Botulinum toxin (BT) therapy is a complex and highly individualised therapy defined by treatment algorithms and injection schemes describing its target muscles and their dosing. ...For this, we collaborated with IAB-Interdisciplinary Working Group for Movement Di …
Botulinum toxin (BT) therapy is a complex and highly individualised therapy defined by treatment algorithms and injection sche …
Botulinum toxin treatment in parkinsonism.
Anandan C, Jankovic J. Anandan C, et al. J Neurol Sci. 2024 Jan 15;456:122810. doi: 10.1016/j.jns.2023.122810. Epub 2023 Nov 26. J Neurol Sci. 2024. PMID: 38056063 Review.
Botulinum toxin (BoNT) was approved by the United States Food and Drug Administration (FDA) in 1989 for facial movement disorders and strabismus, but since that time its indications have been expanding beyond neurologic and ophthalmologic disorders. This article is …
Botulinum toxin (BoNT) was approved by the United States Food and Drug Administration (FDA) in 1989 for facial movement disorders and …
Diagnosis and Management of Tremor.
Louis ED. Louis ED. Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1143-58. doi: 10.1212/CON.0000000000000346. Continuum (Minneap Minn). 2016. PMID: 27495202 Review.
The clinician should then formulate two sets of differential diagnoses: disorders in which action tremor is the predominant tremor versus those in which resting tremor is the main tremor. ...This article details the clinical features of each of these as well as other tremo …
The clinician should then formulate two sets of differential diagnoses: disorders in which action tremor is the predominant tremor ve …
Genetic Update and Treatment for Dystonia.
Koptielow J, Szyłak E, Szewczyk-Roszczenko O, Roszczenko P, Kochanowicz J, Kułakowska A, Chorąży M. Koptielow J, et al. Int J Mol Sci. 2024 Mar 22;25(7):3571. doi: 10.3390/ijms25073571. Int J Mol Sci. 2024. PMID: 38612382 Free PMC article. Review.
299 results